Page last updated: 2024-11-03

prazosin and Peripheral Vascular Diseases

prazosin has been researched along with Peripheral Vascular Diseases in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kohout, J1
Hůzl, F1
Bejcková, H1
Soukupová, K1

Trials

1 trial available for prazosin and Peripheral Vascular Diseases

ArticleYear
Treatment of vascular disease caused by vibration.
    Central European journal of public health, 1995, Volume: 3 Suppl

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Cumulative Trauma Disorders; Gases; Humans; Injections, S

1995